• Neurophth Closes RMB 400 Million Series B Financing prnasia
    February 10, 2021
    Neurophth Biotechnology Ltd. announced the closing of a RMB 400 million ($61.9 million USD) Series-B financing with a premier syndicate of investors, co-led by Guofang Capital and InnoVision Capital.
  • A third of doctors considering leaving clinical practice pharmatimes
    December 07, 2018
  • 100,000 vacancies contribute to NHS crisis pharmafile
    December 20, 2017
PharmaSources Customer Service